Clinical Trial

at the Medical University of Graz

read more

Tremitas develops “Clinical Thermometer” for Parkinson’s Patients

For all kind of diseases there are measuring devices that can be used by patients at home: for fever there is a clinical thermometer, for high blood…

some image

Because of this the Tremipen® was developed. The initial thought was to develop a pen shaped measurement device that can capture the uncontrollable shaking of Parkinson’s and Essential Tremor patients. Due to measurements on a regular basis for a longer period it can be analysed how the shaking behaves or changes.

The Tremipen® offers three important advantages:

  • Tremor measurements are possible outside from clinics and laboratories
  • Patients get the opportunity to measure their tremor by themselves and can take the results to their next doctor’s appointment
  • It can be checked if and how a medication is influencing the tremor

The operating principle

The operating principle is explained very quick. At a clinical thermometer a button is pushed, after that the temperature is measured, then the result is shown on the display.

The Tremipen® works with the same operating principle. Patients activate the sensor with a push to the button and hold it in their hands. After 30 seconds the Tremipen® has measured the parameters and the results are shown on the display. The simple parameter, stated in milli-G, shows how strong the shaking was. Patients can perform measurements as often as they want and can create a course of their disease for themselves and their doctors. If the result is increasing, the shaking increased and vice versa; if it stays nearly the same, the shaking has not changed.


The project status

The Tremipen® was clinically tested at the Medical University of Graz under the leadership of Assoz. Univ.-Prof. Dr. Petra Schwingenschuh. The results of the trial showed, that the pen is not only as reliable as the actual used clinical devices, but also has a strong connection to the tremor assessment of clinical experts. From 11th of April, the World Parkinson’s Day, the Tremipen® can be pre-ordered in a crowdfunding campaign on the online platform Indiegogo. With the support of every person, the certification process as a medical device can be finished. The first 50 purchasers can pre-order the Tremipen® for a limited introductory price of € 249,- (instead of € 599,-)

For further information about the Tremipen® visit the website, there you can also subscribe for the newsletter.